News

Waitrose launches omega 3 chicken

21 Jun 2016

UK supermarket Waitrose has announced that it will introduce what it claims is the UK’s first chicken that is a source of omega 3, describing it as a groundbreaking move for a British supermarket.

Waitrose launches omega 3 chicken

UK supermarket Waitrose has announced that it will introduce what it claims is the UK’s first chicken that is a source of omega 3, describing it as a groundbreaking move for a British supermarket.

The company notes that research undertaken in 2013 showed that people with the highest levels of omega 3 had a 40% reduction in cardiovascular related deaths compared to people with the lowest levels. Optimum health benefits are obtained from a daily intake of 250mg of omega 3 fatt¬y acids as part of a healthy balanced diet and lifestyle.

Despite leading authorities recommending regular consumption of foods containing omega 3, research suggests that only 23% of the UK’s adult population consumes the recommended intake, generally classified as at least one portion of oily fish per week. Intake levels are particularly low in children and young people.

The new omega 3 chicken, which is said to be unique to Waitrose, is produced by Moy Park on family farms in Northern Ireland to Waitrose’s bespoke standards, which include plenty of natural light and more space than the industry standards, allowing the birds to display natural behaviour. The chicken is enriched by feeding the birds on a diet containing an algae naturally rich in omega 3. The taste and appearance of the chicken is the same as birds reared on a conventional diet.

The innovation has been brought to market by Waitrose in partnership with its chicken supplier Moy Park and animal nutrition specialist Devenish Nutrition. The supermarket said that the project, which has taken a decade to bring to market, came about as a result of concerns within the medical community that consumers were not including enough sources of omega 3 in their diets; this is of particular concern in children, who often do not like oily fish. To help improve intake, the idea was conceived of developing a more popular protein containing a source of omega 3. Chicken is Waitrose’s top selling protein.

“Our research is showing that this nutritional breakthrough has the potential to have a significant impact on health,” said Heather Jenkins, Waitrose’s Agricultural Director. “What’s exciting is that it’s improving the nutritional content of something which customers already consume frequently as part of their diets.”

Initial trials are said to have demonstrated that people eating enriched chicken for just five weeks have increased levels of Omega 3 polyunsaturated fatty acids and see measurable effects on their cardiovascular health.

Initial testing was carried out on 30 healthy participants whose omega 3 levels were measured after one, three and five weeks of eating three servings per week of omega 3 enriched chicken meat. On average participants saw their levels of omega 3s increase by 12%.

A total of 10 different new products, including whole chickens, breast fillets and thigh meat went on sale from June 15.

Related news

Our most-read articles of 2025

Our most-read articles of 2025

23 Dec 2025

From trade tariffs to heavy metals in protein, we look back at some of the industry’s highlights of 2025 and round up our most-read stories of the year.

Read more 
Bigging up bean-based products and consumption in Britain

Bigging up bean-based products and consumption in Britain

19 Dec 2025

Non-profit organisation the Food Foundation has launched a campaign, “Bang in Some Beans”, designed to increase UK consumers’ legume consumption.

Read more 
Ingredient transparency key to success in European natural health market

Ingredient transparency key to success in European natural health market

12 Dec 2025

Europe’s $40.7 billion supplements market is growing fast, fuelled by demand for products that support healthy ageing, mental wellbeing, and preventive health, say experts.

Read more 
Whole Foods Market forecasts fibre frenzy for 2026

Whole Foods Market forecasts fibre frenzy for 2026

11 Dec 2025

Whole Foods Market has released its top 2026 trends, predicting that a fibre frenzy will take place next year as health-conscious consumers seek out nutritious, filling options.

Read more 
Sorghum emerges as better-for-you hero ingredient

Sorghum emerges as better-for-you hero ingredient

9 Dec 2025

With the launch of Novak Djokovic’s sorghum-based brand, the grain’s popularity in the better-for-you snacking sphere is on the rise, thanks to its nutritional and sensory properties.

Read more 
Innovation promise in 'maturing' plant-based dairy alternatives market

Innovation promise in 'maturing' plant-based dairy alternatives market

8 Dec 2025

Plant-based dairy is a maturing market that still faces significant hurdles around taste, functionality, nutrition, and price, but industry is innovating fast, according to experts speaking at Fi Europe.

Read more 
Celebrating the winners of the Fi Europe Innovation Awards 2025

Celebrating the winners of the Fi Europe Innovation Awards 2025

3 Dec 2025

Food industry stakeholders celebrated as the winners of the Fi Europe Innovation Awards were announced at a ceremony in Paris.

Read more 
Apply now for the Vitafoods Europe Innovation Awards 2026!

Apply now for the Vitafoods Europe Innovation Awards 2026!

28 Nov 2025

Entries for the Vitafoods Europe Innovation Awards 2026 are now open! Game-changing companies have until 27 February to submit their entry across eight categories for the chance to win big.

Read more 
Concerns swirl around cinnamon’s compliance with EU law

Concerns swirl around cinnamon’s compliance with EU law

25 Nov 2025

Cinnamon may be a top functional ingredient, but it needs stronger protocols to ensure it meets EU food safety laws and quality standards, say researchers.

Read more 
Bone broth: From old-fashioned to en vogue

Bone broth: From old-fashioned to en vogue

24 Nov 2025

OXO’s entry into bone broth has turned the spotlight on this small but high-performance category – and there is still scope for growth, especially in the area of GLP-1 support.

Read more